Fortis Healthcare Ltd. (NSE: FORTIS, BSE: 532843) is a Gurugram, Haryana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹53,821 Cr, it ranks #184 by market cap among the 6,189 Indian listed companies on FinBizNet, and #5 of 42 in Hospitals and Healthcare Centers. At ₹712.90 (as of 26 Oct 2026), the share price is 33.2% below its 52-week high of ₹1,067.70 and 1.1% above its 52-week low of ₹704.95. The share price is down 34.9% over one year and down 24.9% over three months.
| Current Price | ₹712.90 |
|---|---|
| Market Cap | ₹53,821 Cr |
| NSE Symbol | FORTIS |
| BSE Code | 532843 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 51.7 |
| Return on Equity | 11.01% |
| Return on Assets | 6.84% |
| 52-Week Range | ₹704.95 – ₹1,067.70 |
| 1-Year Price Change | -34.9% |
| 3-Month Price Change | -24.9% |
| Beta (1Y) | 0.51 |
| Dividend Yield | 0.14% |
| Headquarters | Gurugram, Haryana |
| Website | www.fortishealthcare.com |
| Revenue | ₹2,545 Cr |
|---|---|
| Net Profit | ₹268 Cr |
| Net Margin | 10.5% |
| EPS (Basic) | ₹3.53 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplant, rheumatology, thoracic surgery, transfusion medicine, urology, medical generics, endocrine surgery, and other support specialties, as well as treat infectious dise
1. Healthcare Services-This segment manages and operates a network of multi-specialty hospitals. 2. Diagnostics-This segment manages and operates a network of diagnostic centers. 3. Inter Segment-0 4. Un-Allocable Assets-0
1. Healthcare-85.2% 2. Diagnostics-16.7%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,11,146 Cr | 57.3 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹79,889 Cr | 79.2 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹79,516 Cr | 55.4 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹56,125 Cr | 85.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹53,821 Cr | 51.7 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹31,861 Cr | 57.4 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹26,615 Cr | 110.3 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹15,024 Cr | 113.4 | 8.31% | ₹614 Cr | -9.3% |
| Rainbow Children'S Medicare Limited | ₹11,879 Cr | 42.7 | 17.94% | ₹470 Cr | -11.6% |
Listed by market capitalisation. Ratios are shown for context only.
Fortis Healthcare Ltd. is trading at ₹712.90, with a market capitalisation of ₹53,821 Cr.
Fortis Healthcare Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Fortis Healthcare Ltd. has a P/E of 51.7 and a return on equity of 11.01%.
Fortis Healthcare Ltd. is listed on the NSE under the symbol FORTIS and on the BSE under the scrip code 532843.
Fortis Healthcare Ltd.'s share price is down 34.9% over one year and down 24.9% over three months. Its 52-week range is ₹704.95 to ₹1,067.70.
In Q1 FY27, Fortis Healthcare Ltd. reported revenue of ₹2,545 Cr and net profit of ₹268 Cr, with basic EPS of ₹3.53 (consolidated, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.